Highly purified batches of pharmaceutical grade 1-deoxygalactose nojirimycin compounds

Methods for producing active pharmaceutical ingredient (API) grade migalastat hydrochloride are provided, as well as methods for purifying intermediate grade migalastat hydrochloride. Further provided are methods of producing [(2R, 3S, 4R, 5S)-1-butyl-2-(hydroxymethyl) piperidine-3, 4, 5-triol hydro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHETH, KAMLESH, TESLER SERGEY
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SHETH, KAMLESH
TESLER SERGEY
description Methods for producing active pharmaceutical ingredient (API) grade migalastat hydrochloride are provided, as well as methods for purifying intermediate grade migalastat hydrochloride. Further provided are methods of producing [(2R, 3S, 4R, 5S)-1-butyl-2-(hydroxymethyl) piperidine-3, 4, 5-triol hydrochloride (rucastat hydrochloride) and other 1-deoxygalactose nojirimycin compounds, as well as methods of purifying the intermediate grade rucastat hydrochloride and other 1-deoxygalactose nojirimycin compounds. 提供了生产活性药物成分(API)级盐酸米加司他的方法,以及用于纯化中间体级盐酸米加司他的方法。进一步提供了生产盐酸[(2R,3S,4R,5S)-1-丁基-2-(羟甲基)哌啶-3,4,5-三醇(盐酸卢卡司他)和其他1-脱氧半乳糖野尻霉素化合物的方法,以及纯化中间体级盐酸卢卡司他和其他1-脱氧半乳糖野尻霉素化合物的方法。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116710185A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116710185A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116710185A3</originalsourceid><addsrcrecordid>eNqNzLEKwjAQgOEsDqK-w_kABYOoXaUonZzEtZzJtT1JcyFJwby9Dj6A0798_Ev1aHkYXYEwR-6ZLDwxm5ESSA9hxDihoTmzQQdDREugK0vyLgM6NFkSgZcXR56KYQ9GpiCzt2mtFj26RJtfV2p7vdybtqIgHaXwvXrKXXPT-njSO10fzvt_zAdaNToo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Highly purified batches of pharmaceutical grade 1-deoxygalactose nojirimycin compounds</title><source>esp@cenet</source><creator>SHETH, KAMLESH ; TESLER SERGEY</creator><creatorcontrib>SHETH, KAMLESH ; TESLER SERGEY</creatorcontrib><description>Methods for producing active pharmaceutical ingredient (API) grade migalastat hydrochloride are provided, as well as methods for purifying intermediate grade migalastat hydrochloride. Further provided are methods of producing [(2R, 3S, 4R, 5S)-1-butyl-2-(hydroxymethyl) piperidine-3, 4, 5-triol hydrochloride (rucastat hydrochloride) and other 1-deoxygalactose nojirimycin compounds, as well as methods of purifying the intermediate grade rucastat hydrochloride and other 1-deoxygalactose nojirimycin compounds. 提供了生产活性药物成分(API)级盐酸米加司他的方法,以及用于纯化中间体级盐酸米加司他的方法。进一步提供了生产盐酸[(2R,3S,4R,5S)-1-丁基-2-(羟甲基)哌啶-3,4,5-三醇(盐酸卢卡司他)和其他1-脱氧半乳糖野尻霉素化合物的方法,以及纯化中间体级盐酸卢卡司他和其他1-脱氧半乳糖野尻霉素化合物的方法。</description><language>chi ; eng</language><subject>PERFORMING OPERATIONS ; PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL ; SEPARATION ; TRANSPORTING</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230905&amp;DB=EPODOC&amp;CC=CN&amp;NR=116710185A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230905&amp;DB=EPODOC&amp;CC=CN&amp;NR=116710185A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHETH, KAMLESH</creatorcontrib><creatorcontrib>TESLER SERGEY</creatorcontrib><title>Highly purified batches of pharmaceutical grade 1-deoxygalactose nojirimycin compounds</title><description>Methods for producing active pharmaceutical ingredient (API) grade migalastat hydrochloride are provided, as well as methods for purifying intermediate grade migalastat hydrochloride. Further provided are methods of producing [(2R, 3S, 4R, 5S)-1-butyl-2-(hydroxymethyl) piperidine-3, 4, 5-triol hydrochloride (rucastat hydrochloride) and other 1-deoxygalactose nojirimycin compounds, as well as methods of purifying the intermediate grade rucastat hydrochloride and other 1-deoxygalactose nojirimycin compounds. 提供了生产活性药物成分(API)级盐酸米加司他的方法,以及用于纯化中间体级盐酸米加司他的方法。进一步提供了生产盐酸[(2R,3S,4R,5S)-1-丁基-2-(羟甲基)哌啶-3,4,5-三醇(盐酸卢卡司他)和其他1-脱氧半乳糖野尻霉素化合物的方法,以及纯化中间体级盐酸卢卡司他和其他1-脱氧半乳糖野尻霉素化合物的方法。</description><subject>PERFORMING OPERATIONS</subject><subject>PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL</subject><subject>SEPARATION</subject><subject>TRANSPORTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzLEKwjAQgOEsDqK-w_kABYOoXaUonZzEtZzJtT1JcyFJwby9Dj6A0798_Ev1aHkYXYEwR-6ZLDwxm5ESSA9hxDihoTmzQQdDREugK0vyLgM6NFkSgZcXR56KYQ9GpiCzt2mtFj26RJtfV2p7vdybtqIgHaXwvXrKXXPT-njSO10fzvt_zAdaNToo</recordid><startdate>20230905</startdate><enddate>20230905</enddate><creator>SHETH, KAMLESH</creator><creator>TESLER SERGEY</creator><scope>EVB</scope></search><sort><creationdate>20230905</creationdate><title>Highly purified batches of pharmaceutical grade 1-deoxygalactose nojirimycin compounds</title><author>SHETH, KAMLESH ; TESLER SERGEY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116710185A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>PERFORMING OPERATIONS</topic><topic>PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL</topic><topic>SEPARATION</topic><topic>TRANSPORTING</topic><toplevel>online_resources</toplevel><creatorcontrib>SHETH, KAMLESH</creatorcontrib><creatorcontrib>TESLER SERGEY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHETH, KAMLESH</au><au>TESLER SERGEY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Highly purified batches of pharmaceutical grade 1-deoxygalactose nojirimycin compounds</title><date>2023-09-05</date><risdate>2023</risdate><abstract>Methods for producing active pharmaceutical ingredient (API) grade migalastat hydrochloride are provided, as well as methods for purifying intermediate grade migalastat hydrochloride. Further provided are methods of producing [(2R, 3S, 4R, 5S)-1-butyl-2-(hydroxymethyl) piperidine-3, 4, 5-triol hydrochloride (rucastat hydrochloride) and other 1-deoxygalactose nojirimycin compounds, as well as methods of purifying the intermediate grade rucastat hydrochloride and other 1-deoxygalactose nojirimycin compounds. 提供了生产活性药物成分(API)级盐酸米加司他的方法,以及用于纯化中间体级盐酸米加司他的方法。进一步提供了生产盐酸[(2R,3S,4R,5S)-1-丁基-2-(羟甲基)哌啶-3,4,5-三醇(盐酸卢卡司他)和其他1-脱氧半乳糖野尻霉素化合物的方法,以及纯化中间体级盐酸卢卡司他和其他1-脱氧半乳糖野尻霉素化合物的方法。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN116710185A
source esp@cenet
subjects PERFORMING OPERATIONS
PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
SEPARATION
TRANSPORTING
title Highly purified batches of pharmaceutical grade 1-deoxygalactose nojirimycin compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A37%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHETH,%20KAMLESH&rft.date=2023-09-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116710185A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true